Giorgia Guglielmi

Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.

Gut microbes could improve symptoms of neurodegenerative disorder

In mice with a genetic mutation linked to ALS, altering the gut microbiota could prevent or improve disease symptoms, a study published in Nature has found.

Ketogenic diets could alter the gut microbiota, reduce inflammation

A new study, published in Cell, suggests that ketogenic diets could be used as a therapy for autoimmune disorders of the gut.

Fermented foods could be a source of health-promoting bacteria

Fermented foods such as yoghurt and cheese could be a source of health-promoting bacteria, according to a new study.

Catalog of tumor microbiotas finds bacteria living inside many cancer cells

Researchers have created a catalog of the bacteria associated with all the cancer types. The findings could help to enhance the actions of anticancer drugs.

Bacterial viruses could modulate the gut microbiota to fight colorectal cancer

Researchers developed a new tool to modulate the gut microbiota for neutralizing the tumor-promoting microenvironment.

How the microbiota shapes the development of the immune system

A. Macpherson et al. reviewed studies that looked at the interaction between the gut microbiota and their mammalian hosts, from fetal development to the early postnatal period.

Cholesterol-lowering drugs could influence the gut microbiota in obese people

Obese people have a gut microbiota that is associated with inflammation. But those who take statins have a healthier gut microbiota, a new study (Nature) found.

AGA release new guidelines for taking probiotics

The American Gastroenterological Association (AGA) evaluated available evidence on clinical efficacy of probiotics for most digestive conditions.

Drug halts C. difficile infection, promotes recovery of the microbiota after antibiotic treatment

Ebselen may protect from C. difficile-associated tissue damage and bolster recovery of the microbiota after antibiotic treatment.

Gut microbiota could inhibit the growth of antibiotic-resistant bacteria

A new study shows that interactions with the resident gut microbiota could suppress the proliferation and antibiotic-resistance evolution of superbugs.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top